En
Untargeted lipidomics research is based on LC-MS/MS technology for broad spectrum analysis of lipids in biological samples. With high-resolution mass spectrometry, it maximizes the analysis of changes in lipid composition and expression in various biological processes.
High-resolution mass spectrometry platform.
Matched LipidSearchTM database 1.7 million lipid molecules mapping.
Average 2500+ lipid molecules each sample detection.
Sample type | sample | Recommended | Biological duplication |
Body fluid | Seminal plasma. serum, urine, saliva, sperm, secretions…… | ≥200 μL/sample | Clinical ≥30 samples/group Animal ≥10 samples /group Plant ≥6 samples /group Cell ≥6 samples /group |
Animal tissue | Cancer and adjacent non-tumor, brain, liver tissues…… | ≥200 mg/sample | |
Plant | Roots, stems, leaves | ≥200 mg/sample | |
Stool | Feces, intestinal contents | ≥200 mg/sample | |
Cells | Suspension and adherent cells | ≥107 /sample | |
Bacteria | Microbes (bacterial precipitate) | ≥200 mg/sample | |
Others | others | Customized |
INOMIXO can provide a variety of bioinformatics and customized analysis services in addition to the charts mentioned above. For more lipidomics analysis needs, please contact info@inomixo.com.
INOMIXO's untargeted lipidomics services provide comprehensive lipid profile analysis, uncovering insights into the role of lipids in various biological processes and diseases. Our untargeted lipidomics services have key applications across several research areas, including:
Disease Mechanism and Biomarker Discovery: Lipidomics helps identify lipid-related biomarkers and metabolic pathways in diseases like cancer, cardiovascular disorders, and metabolic diseases, offering insights into disease mechanisms and potential therapeutic targets.
Neurodegenerative Diseases: By profiling lipid changes in the brain, our untargeted lipidomics services support research into diseases like Alzheimer's and Parkinson's, revealing how lipid metabolism impacts disease progression and aiding in biomarker discovery for early detection.
Cancer and Cardiovascular Research: Altered lipid profiles are linked to cancer cell growth and cardiovascular diseases. Our lipidomics services provide critical insights into lipid-driven processes, supporting cancer research and studies on lipid-related cardiovascular risk factors.
Toxicology and Drug Development: INOMIXO's untargeted lipidomics services are used to assess how environmental toxins or drug candidates affect lipid metabolism, helping identify lipid biomarkers for toxicity and facilitating drug development targeting lipid pathways.
Call Us
Address
160E Tasman Drive, San Jose, CA 95134
English
